MEDI NOLT 300 by Meditech is a pharmaceutical-grade four-ester Nandrolone blend combining Nandrolone Propionate, Nandrolone Phenylpropionate, Nandrolone Decanoate, and Nandrolone Laurate in a single oil-based injectable formulation at 300 mg/mL. The inclusion of four nandrolone esters spanning short-to-ultra-long release profiles represents a pharmacokinetically comprehensive multi-phase delivery strategy, documented in anabolic research literature as a formulation approach designed to maintain continuous and stable nandrolone serum concentrations across an extended dosing interval.
 
✔ Key Research Insights
Studied for its multi-phase pharmacokinetic profile, with short-acting propionate and phenylpropionate esters contributing rapid-onset nandrolone availability and longer-acting decanoate and laurate esters providing sustained and prolonged release in research subjects
Investigated for nandrolone's documented effects on lean mass parameters, protein synthesis, and nitrogen retention across comparative anabolic-androgenic steroid research literature
Researched for its influence on collagen synthesis and connective tissue parameters, with joint-related effects representing a pharmacologically distinct area of nandrolone research interest relative to other anabolic compounds in clinical observations
Examined for nandrolone's erythropoietic activity, with documented effects on red blood cell production and oxygen-carrying capacity noted across subject populations in clinical research
Documented for the continuous anabolic activity profile conferred by the four-ester architecture, associated with minimized serum nandrolone fluctuation between administrations in pharmacokinetic research
Manufactured by Meditech to pharmaceutical-grade purity and precision blending standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: MEDI NOLT 300
Molecules:
Nandrolone Propionate: 60 mg/mL
Nandrolone Phenylpropionate: 60 mg/mL
Nandrolone Decanoate: 90 mg/mL
Nandrolone Laurate: 90 mg/mL
Total Concentration: 300 mg/mL
Appearance: Oil-based solution
Packing: Sterile 10 mL clear glass vial with red flip-off cap and labeled box
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
MEDI NOLT 300 delivers four ester-modified forms of nandrolone simultaneously via intramuscular injection, each undergoing enzymatic hydrolysis at a distinct rate to release free nandrolone into systemic circulation across a staggered multi-phase timeline in research subjects. Nandrolone propionate, as the shortest-acting ester in the blend, undergoes rapid hydrolysis following administration, producing an early elevation of circulating nandrolone and establishing pharmacological activity within a compressed timeframe. Nandrolone phenylpropionate contributes a short-to-medium release phase, extending initial anabolic activity beyond the propionate window. Nandrolone decanoate, one of the most extensively researched nandrolone esters in clinical literature, provides a sustained medium-to-long release phase, while nandrolone laurate — among the longest-acting nandrolone esters documented in pharmacological research — maintains prolonged plasma nandrolone concentrations across the final and most extended phase of the dosing interval. Nandrolone itself is a 19-nor anabolic-androgenic steroid that exerts primary effects through androgen receptor binding in muscle tissue, with documented downstream influences on protein synthesis and nitrogen retention. Notably, nandrolone has also been investigated for its effects on collagen biosynthesis and synovial parameters, with connective tissue and joint-related research representing a pharmacologically distinct area of clinical interest relative to other anabolic-androgenic compounds. Erythropoietic stimulation via increased erythropoietin production has additionally been documented across nandrolone research literature.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and precision blending standards
Four-ester exclusive nandrolone formulation with a pharmacokinetically comprehensive multi-phase release profile spanning rapid-onset through ultra-long-acting activity within a single 300 mg/mL injectable solution
Connective tissue and joint parameter research representing a clinically distinct pharmacological area of interest for nandrolone relative to other anabolic-androgenic compounds
Supplied in a clearly labeled sterile glass vial with secure flip-off cap, consistent with pharmaceutical packaging standards
Widely referenced in anabolic pharmacology research under the nandrolone propionate, nandrolone phenylpropionate, nandrolone decanoate, and nandrolone laurate designations